Mucormycosis in Indian COVID-19 patients: insight into its patho-genesis, clinical manifestation, and management strategies

• Main Authors: Ram Kumar Sahu, -, Mounir M Salem-Bekhit, -, Bedanta Bhattacharjee, -, Yosif Almoshari, -, Abu Md Ashif Ikbal, -, Meshal Alshamrani, -, Alakesh Bharali, -, Ahmad Salawi, -, Retno Widyowati, -, Abdulrahman Alshammari, -, Ibrahim Elbagory, -
• Format: Article PeerReviewed
• Language: English; English; English
• Published: Multidisciplinary Digital Publishing Institute (MDPI) 2023
• Subjects: R Medicine; RS Pharmacy and materia medica; RS1-441 Pharmacy and materia medica; RS200-201 Pharmaceutical dosage forms
• Online Access: https://repository.unair.ac.id/125497/1/C-25_artikel.pdf; https://repository.unair.ac.id/125497/2/Kualitas%20Karil%20C-25.pdf; https://repository.unair.ac.id/125497/3/C-25_similarity.pdf; https://repository.unair.ac.id/125497/; https://www.mdpi.com/2079-6382/10/9/1079; https://doi.org/10.3390/antibiotics10091079
• Institution: Universitas Airlangga

Mucormycosis in patients who have COVID-19 or who are otherwise immunocompromised has become a global problem, causing significant morbidity and mortality. Infection is debilitating and fatal, leading to loss of organs and emotional trauma. Radiographic manifestations are not specific, but diagnosis...